Report DescriptionIntroduction
Vaccines empower the human immune system to protect against infection or disease. Vaccines against HIV are being developed, and tested in phases of clinical trials. At present, none of the HIV vaccines are commercially available.
More than 30 HIV candidate vaccines have been tried in roughly 60 Phase I/II trials, involving more than 10,000 healthy volunteers. A large portion of these trials have been conducted in the United States & Europe, and a few in developing countries such as Brazil, Peru, China, and Thailand. The outcomes have affirmed the safety of the vaccines, and have given important scientific information to create fresher eras of candidate vaccines with better capacity to induce anti-HIV specific immune responses.
This research report provides in-depth information about the various market segments. It shall also provide qualitative information about the current and upcoming trends in HIV vaccines market, globally.
The market is majorly divided on the basis of phases of clinical trials and regions. Globally, North America commands the largest market share of around 44% of the global market. This large share is majorly attributed to high adoption of various HIV vaccine trials coupled with the technological advancement in the region. North America is one of the important partners for HIV prevention & research for the development of HIV vaccine, as well as for reduction and prevention of HIV. It has been revealed that more than $600 million a year is invested into HIV vaccine R&D, with the major share coming from the US National Institutes of Health. United States was the first country to carry out the first Phase I trial of an HIV candidate vaccine in 1987. Since then, more than 30 distinctive candidate vaccines have been developed by many organizations, utilizing various technologies mostly in the United States.
Growing number of market players, increasing awareness about HIV prevention among various nations, rising prevalence of HIV, and rising funds for HIV vaccines research, are some of the key factors propelling the growth of HIV vaccines market. However, hindrance during HIV vaccine approval process is limiting the market growth to a great extent.
Some of the key players of the market are GlaxoSmithKline plc (U.K.), SANOFI (France), Argos Therapeutics, Inc. (U.S.), Bionor Pharma ASA (Norway), Janssen Global Services, LLC (U.S.), GENECURE LLC (U.S.), GeoVax (U.S.), GENVEC, INC. (U.S.), PaxVax Corporation (U.S.), and Inovio Pharmaceuticals, Inc. (U.S.).

STUDY OBJECTIVES OF HIV VACCINES MARKET DEVELOPMENT AND FORECAST TO 2027
• To provide insights about factors, influencing and affecting the market growth
• To provide present and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
• To provide present as well as forecast revenue of the market segments based on products, and sub-segments for global HIV vaccines market
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic and ethical factors that influences the global HIV vaccines market

Key Findings
• The global HIV vaccines market is expected to grow at a CAGR of 5.0% between 2017 and 2027, driven by growth from both developed and emerging markets
• North America contributed more than 44% of the total market size in 2017. Emerging markets such as China and India are expected to generate significant demand for HIV vaccines during the period, 2017-2027
As per the MRFR analysis, the global HIV vaccines market is expected to reach $2.7 billion by 2027. The market in Europe is estimated to be around $ 437 million in 2017 and is anticipated to reach $ 757 million by 2027. Asia-Pacific is expected to grow at a moderate pace during the forecast period.
The reports also cover country level analysis:
• Americas
o North America
 US
 Canada
o South America
• Europe
o Western Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Western Europe
o Easter Europe
• Asia-Pacific
o China
o Japan
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific

世界の商用薬剤分析市場予測2013-2027DATA70126015 / Market Research Future / 2016年11月4日 / 本調査レポートでは、世界の商用薬剤分析市場について調査・分析し、世界の商用薬剤分析市場動向、市場予測、セグメント別分析、主要地域別分析（アメリカ市場、ヨーロッパ市場、アジア市場）、世界市場規模、関連企業分析などを含め、以下の構成でお届けいたします。...Introduction Pharmaceuticals analytics refers to the use of analytical software to analyze and manage biomedical and biological data from life science industries like hospitals, pharmaceutical companies, and laboratories. The global commercial pharmaceutical analytics market was valued at USD 1.0 billion in 2015, and is expected grow at a CAGR of around 20% during the forecast period. This rapid growth is majorly attributed to growing adoption of new technologies & analytical tools in process streamlining, as well as the growing pharmaceutical industry, especially in developing nations. On the other hand, lack of skilled professionals and high software cost are major obstacles...

世界の嚢胞性線維症（CF症）治療市場分析・予測MRF709024 / Market Research Future / 2016年9月21日 / Market Research Futureが出版した本調査レポートでは、世界の嚢胞性線維症（CF症）治療市場について調査・分析し、世界の嚢胞性線維症（CF症）治療市場動向、市場予測、セグメント別分析、主要地域別分析（アメリカ市場、ヨーロッパ市場、アジア市場）、世界市場規模、関連企業分析などを含め、以下の構成でお届けいたします。...Introduction:Cystic fibrosis is a chronic, genetic disease which affects the productivity of the body leading to severe disability and early death. Symptoms of cystic fibrosis include frequent lung infections, diarrhea, and poor growth of the body. The global cystic fibrosis market is expected to reach USD 8852.2 million by 2022 at a CAGR of 13.5% during the forecast period. The global cystic fibrosis market is segmented on the basis of treatment method which includes Medication, Devices and Other Treatments. Medicines capture the maximum share in the cystic fibrosis market. Medication segment accounted market share in all the regions across the...

嚢胞性線維症（CF）治療の世界市場予測MRF704005 / Market Research Future / 2017年4月 / ...Introduction The global cystic fibrosis market was valued at $ 3145.7 million in 2015 and expected to reach at $ 8852.2 million by 2022 at a CAGR of 13.5 % during the forecast period. The major factors responsible for the growth of global cystic fibrosis market are; development of new drugs and therapies, financial support from interest organizations in research and development of cystic fibrosis drugs and others. The growth barriers are high cost of the drugs and treatment among others. The market is majorly categorized on the basis of treatment method types which is further segmented into medication, devices...

低分子APIの世界市場予測MRF706003 / Market Research Future / 2016年8月1日 / ...Introduction The global small molecule API market was valued at $ 132,877.3 million in 2016 and expected to reach $ 279,687.1 million by 2027 at a CAGR of 7 % during the forecast period. The major factors responsible for the growth of global Small molecule API market are growing demand for newly developed small molecules drugs, growing trend of outsourcing and growing pharmaceutical industry in developing nations. The growth barriers are and austerity measures in Europe among others. The market is majorly categorized on the basis of types which is further segmented into synthetic/chemical API and biological API. On the...

液体クロマトグラフィー装置の世界市場予測MRF706004 / Market Research Future / 2017年4月6日 / ...Introduction The global liquid chromatography instruments market was valued at $ 5,052.5 million in 2016 and expected to reach $ 11,194.4 million by 2027 at a CAGR of 7.5 % during the forecast period. The major factors responsible for the growth of global liquid chromatography instruments market are technological advancement in chromatography instruments, increased automation, increasing demand in pharmaceutical and biotechnological companies, and also in drug discovery and screening of disorders. The growth barriers are high cost of instruments, limited availability of these products in some regions, stringent and changing government policies and regulations among others. The market is majorly...

世界の自動試験装置（ATE）市場分析・予測DATA70126012 / Market Research Future / 2016年10月12日 / 本調査レポートでは、世界の自動試験装置（ATE）市場について調査・分析し、世界の自動試験装置（ATE）市場動向、市場予測、セグメント別分析、主要地域別分析（アメリカ市場、ヨーロッパ市場、アジア市場）、世界市場規模、関連企業分析などを含め、以下の構成でお届けいたします。...Report DescriptionIntroduction Automated Test Equipment is used for assembly line testing of products in industries such as electronics, hardware, software, and semiconductors. It is a computer controlled electronic device which performs testing based on functionality and performance. The global automated test equipment market has been valued at USD 3,599 million in 2016, and is expected to reach USD 4,422 million by 2022. Rising complexities in the design of consumer electronics, growing automotive market, and high demand of efficient automated test equipment devices are the key growth drivers of automated test equipment market. However, growing competition and the high capital requirements...

米国のタイル用接着剤市場動向・予測MRF711027 / Market Research Future / 2017年9月19日 / ...U.S. Tile Adhesive Market Information- by type (cementitious adhesive, dispersion adhesive and reactive resin adhesive), by end user (residential and non-residential)-forecast till 2023Market Synopsis of US Tile Adhesive Market: Economic slowdown in 2008-09 had an adverse effect on the construction sector of U.S market. However, the market dynamics have changed and the construction section is regaining its pace in the U.S market. In line with the latter trends, the U.S market has witnessed upsurge in various reconstruction activities, with increasing consumer preference towards more appealing tiles. Also, the penetration of ceramic tiles in various applications in the residential and commercial...

世界の超低温フリーザー市場予測2013-2022DATA70126024 / Market Research Future / 2017年1月3日 / 本調査レポートでは、世界の超低温フリーザー市場について調査・分析し、世界の超低温フリーザー市場動向、市場予測、セグメント別分析、主要地域別分析（アメリカ市場、ヨーロッパ市場、アジア市場）、世界市場規模、関連企業分析などを含め、以下の構成でお届けいたします。...Introduction Ultra-low temperature freezers are bio-freezers that are utilized for the preservation of viruses, bacteria, drugs, enzymes, chemicals, and cell preparations tissue samples. The global ultra-low temperature freezer market was valued at USD 701.48 million in 2015 and is expected to reach at USD 866.93 million by 2022. The expected moderate growth is majorly attributed to growing prevalence of chronic diseases, need for high-efficiency products, and demand for environment-friendly refrigerators. On the other hand, the high cost and maintenance involved, along with ethical issues in embryo freezing are factors restraining the growth of this market. The market has been segmented...

オリゴヌクレオチド・プールの世界市場予測MRF706014 / Market Research Future / 2017年4月1日 / ...Introduction The Global Oligonucleotide pool market was valued at $ 1,292.8 million in 2016 and expected to reach at $2,324 million by 2022 at a CAGR of 8.5% during the forecast period. The major factors responsible for the growth of global Oligonucleotide pool market are big pharmaceutical companies investing in oligonucleotide therapeutics for drug development, increased involvement of CMOs in manufacturing therapeutic oligonucleotides and wide application areas offered by the oligonucleotides, among others. The growth barriers are complexity in the technology of manufacturing oligonucleotides and inaccuracy issues for the specific oligonucleotides among others. The market is majorly categorized on the...